🇺🇸 FDA
Pipeline program

ARALAST NP

TAK-883-3001

Approved mab terminated

Quick answer

ARALAST NP for Chronic Obstructive Pulmonary Disease is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Chronic Obstructive Pulmonary Disease
Phase
Approved
Modality
mab
Status
terminated

Clinical trials